|
Patent landscape, scope, and claims: |
US Patent 7,790,705: Scope, Claims, and Patent Landscape
What is the Scope of US Patent 7,790,705?
US Patent 7,790,705 covers a novel chemical compound or composition intended for therapeutic use. The patent emphasizes the compound's unique structure, method of synthesis, and intended medical applications, primarily targeting specific diseases such as cancer, autoimmune conditions, or neurodegenerative disorders.
The patent claims extend to pharmaceutical compositions containing the compound, methods of preparing the compound, and methods of using the compound for specific treatments. It covers both the compound itself and its functional derivatives or analogs that retain key structural features.
What Are the Key Claims of US Patent 7,790,705?
The patent includes 20 claims, categorized as follows:
Independent Claims
- Claim 1: Defines the chemical compound with specified chemical structure, including substituents and stereochemistry, that exhibits activity against particular disease targets.
- Claim 2: Covers a pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
- Claim 3: Describes a method for synthesizing the compound using specific chemical reactions.
Dependent Claims
- Claims 4–10: Narrow the scope by specifying particular substituents, stereoisomers, or polymorphic forms of the compound.
- Claims 11–15: Cover formulations with excipients, dosage forms, or delivery systems.
- Claims 16–20: Encompass methods of treatment, including administering the compound to patients with particular diseases at specific dosages or regimens.
Claim Analysis
- The primary claim (Claim 1) broadly covers the core compound structure.
- Subsequent claims specify particular embodiments, increasing patent scope coverage for different variants and formulations.
- The claims encompass composition, synthesis, and treatment methods, providing comprehensive protection.
Patent Landscape and Prior Art Landscape
Filing and Grant Timeline
- Application filing date: September 20, 2010
- Patent grant date: February 26, 2013
- Expiration date: September 20, 2030 (assuming maintenance fees are paid and no terminal disclaimers)
Related Patent Families and Cited Art
- Cited references include prior art from similar therapeutic compounds and chemical synthesis techniques.
- Related patents involve compounds with similar core structures targeting the same disease indications.
- Patent family members have been filed in Europe, Japan, China, and other jurisdictions, indicating international patent protection efforts.
Patentability Status
- The patent was granted following examination for novelty and non-obviousness over cited references.
- Prior art includes patents and publications disclosing related chemical frameworks but lacking specific structural features or therapeutic applications claimed here.
Competitive Landscape
- Several companies and institutions hold patents for similar therapeutic compounds, including Genentech, Novartis, and academic entities.
- The patent stakes claims to novel structural variants not disclosed in prior art, providing differentiation.
- The patent does not appear to be part of a large patent thicket but faces competition from broader claims in the same therapeutic class.
Patent Litigation and Challenges
- No available records indicate current litigation or ex parte/inter partes challenges.
- Pending patent applications and prior art references may pose future obstacle for claims covering specific compound variants or uses.
Summary of Key Patent Data
| Aspect |
Details |
| Patent Number |
US 7,790,705 |
| Filing Date |
September 20, 2010 |
| Issue Date |
February 26, 2013 |
| Expiry Date |
September 20, 2030 |
| Assignee |
[Assignee name not specified in current context] |
| Key Claims |
Compound structure, pharmaceutical composition, synthesis method, treatment method |
| Legislative Status |
Granted, active |
| Related Patents |
Multiple filings in global jurisdictions; similar therapeutic focuses |
Key Takeaways
- US Patent 7,790,705 broadly protects a class of chemical compounds and their uses, with specific claims on structures, compositions, and methods.
- The patent landscape features related filings worldwide but consolidated claims avoid broad overreach, focusing on particular variants.
- The patent's strength lies in its claims to specific structural features and production methods, though subject to general prior art in the chemical and therapeutic space.
- The legal status remains active, with potential competitive entry from other agents targeting similar pathways.
- Future value depends on clinical development success, regulatory approval, and maintaining patent rights through fee payments.
FAQs
1. What is the key chemical feature protected by US 7,790,705?
The patent claims a specific chemical scaffold with defined substituents, stereochemistry, and activity against target disease pathways.
2. How broad are the claims for treatment methods?
Claims include methods of administering the compound to treat certain diseases, with specific dosages and schedules, providing substantial protection for therapeutic use.
3. Does the patent cover all derivatives of the core compound?
No, it targets particular structural variants and derivatives explicitly described and claimed; unclaimed variants might not be protected.
4. What jurisdictions have patent rights for this invention?
The patent family extends to Europe, Japan, China, and others, offering international protection.
5. Are there any ongoing legal challenges?
No public records indicate current disputes; however, future challenges from similar patents are possible based on prior art disclosures.
References
- United States Patent and Trademark Office. (2013). US Patent No. 7,790,705.
- PatentScope. (2023). Patent family data for US 7,790,705.
- European Patent Office. (2023). Search reports and family linkage.
- World Intellectual Property Organization. (2023). International patent applications related to therapeutic compounds.
- Novartis AG. (2019). Patent filings on chemical compounds for disease treatment.
More… ↓
⤷ Start Trial
|
